section name header

Information

Editors

PäiviHärkki

Adenomyosis

Essentials

  • The risk of adenomyosis is increased by childbirth, miscarriage, uterine curettage and menorrhagia.
  • The symptoms resemble those of endometriosis.
  • An underdiagnosed disease
  • In fertile age treated like endometriosis
  • Hysterectomy is the best and final treatment for older women with severe symptoms.

General remarks

  • Adenomyosis is characterised by the presence of intramyometrial foci of endometrial glandular and stromal cells (in endometriosis, endometriotic tissue is found outside the uterus).
  • The foci of adenomyosis react to oestrogen in a manner similar to that of endometrium.
  • The foci have either diffuse (usually in the posterior uterine wall) or local (adenomyoma) distribution where a large number of foci become localised in one area.
  • The aetiology remains unclear.
  • The risk of adenomyosis is increased by childbirth, miscarriage, uterine curettage and menorrhagia.
  • Currently adenomyosis is suspected to be associated also with infertility and hence to be more common than previously thought; in 5-70% of women.
  • Most common at the age of 35-50 years
  • Changes are found in 15-20% of hysterectomy patients.
  • About 40% of patients with endometriosis also have adenomyosis.

Symptoms

  • An enlarged and tender uterus
  • Feeling of heaviness in the lower abdomen
  • Chronic lower abdominal pain
  • Infertility; impaired attachment of the embryo to the uterine wall
  • 40-50% have menorrhagia
  • 10-30% have dysmenorrhoea
  • 30-40% are symptom free
  • The symptoms are similar to those of endometriosis Endometriosis and differential diagnosis may prove to be difficult.

Diagnosis

  • Gynaecological examination will reveal uterine tenderness.
  • The ultrasound appearance is that of thickened posterior uterine wall and hypoechoic and blind areas of 1-5 mm in the myometrium.
  • An MRI scan will show thickening of the junctional zone (the interface between the endometrium and myometrium) or a lesion with poorly defined borders (adenomyoma).
  • Diagnosis is challenging and can only be confirmed with a histopathological examination carried out after hysterectomy.
  • Diagnosis may also be obtained by a biopsy taken through hysteroscopy or laparoscopy.

Treatment

  • Prostaglandin inhibitors (anti-inflammatory drugs) reduce menorrhagia and pain in one third of patients.
  • Tranexamic acid halves menorrhagia.
  • Combined oral contraceptive pills as well as progestin pills are effective in reducing both menorrhagia and pain.
  • Levonorgestrel-releasing intrauterine device (IUD) reduces menorrhagia and pain in up to 90% of patients.
  • A gonadotropin-releasing hormone agonist (GnRH agonist) will cause a hypo-oestrogenic state and amenorrhoea leading to both cessation of menorrhagia and pain as well as reduction in the size of the foci (adverse effects include menopausal symptoms if oestrogen/progestogen is not used as add-back therapy).
  • Uterine artery embolization reduces menorrhagia related to adenomyosis and the number of bleeding days.
  • Surgical excision of a localised adenomyoma is possible.
  • The new MRI- or ultrasound-guided focused ultrasound (HIFU, high-intensity focused ultrasound) seems to alleviate the symptoms of adenomyosis.
  • The aforementioned treatments alleviate symptoms but there is no scientific evidence on them in improving fertility.
  • Hysterectomy is the best and final treatment for older women with severe symptoms in whom the above treatment forms have proved ineffective.

    References

    • Maheshwari A, Gurunath S, Fatima F et al. Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes. Hum Reprod Update 2012;18(4):374-92. [PubMed]
    • Zhai J, Vannuccini S, Petraglia F et al. Adenomyosis: Mechanisms and Pathogenesis. Semin Reprod Med 2020;38(2-03):129-143. [PubMed]
    • Struble J, Reid S, Bedaiwy MA. Adenomyosis: A Clinical Review of a Challenging Gynecologic Condition. J Minim Invasive Gynecol 2016;23(2):164-85. [PubMed]
    • Pontis A, D'Alterio MN, Pirarba S et al. Adenomyosis: a systematic review of medical treatment. Gynecol Endocrinol 2016;32(9):696-700. [PubMed]
    • Dueholm M. Minimally invasive treatment of adenomyosis. Best Pract Res Clin Obstet Gynaecol 2018;51:119-137. [PubMed]

Related Keywords

ATC Code:

L02AE01

L02AE02

L02AE03

L02AE04

L02AE05

G02BA03

B02AA02

M01AB01

M01AB02

M01AB05

M01AB08

M01AB15

M01AB51

M01AB55

M01AC01

M01AC02

M01AC06

M01AE01

M01AE02

M01AE03

M01AE11

M01AE17

M01AE51

M01AE52

M01AG01

M01AG02

M01AX01

M01AX17

N02AJ08

N02BA01

N02BA51

N02BA57

Primary/Secondary Keywords